Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes
超重或肥胖 2 型糖尿病患者的强化生活方式干预、代谢组学和衰弱性骨折风险
基本信息
- 批准号:10490260
- 负责人:
- 金额:$ 60.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:BiologicalBlood specimenBody Weight decreasedBone DensityCardiovascular DiseasesCardiovascular systemChemical StructureControl GroupsDiabetes MellitusDiseaseDual-Energy X-Ray AbsorptiometryEducationElderlyEtiologyFastingFractureGoalsHealthHealth ExpendituresHip FracturesHip region structureImageIncidenceIndividualInterventionLeadLinkMeasurementMeasuresMediatingMediationMediator of activation proteinMethodsMolecular TargetMolecular WeightMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusObesityOutcomeOverweightParticipantPatientsPatternPelvisPharmaceutical PreparationsPlasmaPrevention strategyQuality of lifeRandomizedRandomized Clinical TrialsRiskScanningScienceSerumShoulder FracturesSubgroupTrabecular Bone ScoreUpper Extremity FractureUpper armValidationVisitWeight GainWeight maintenance regimenbasebiomarker discoveryblood glucose regulationbonebone healthbone imagingbone lossbone metabolismbone preservationbone qualitybone turnovercardiovascular risk factorcomparison groupdesigndisabilityfollow-upfracture riskfrailtyglycemic controlgroup interventionimprovedinsightlifestyle interventionliquid chromatography mass spectrometrymetabolomicsmortalitynovelnovel markerobese patientsosteoporosis with pathological fracturepredictive markerpreventsecondary outcomeskeletalweight loss intervention
项目摘要
Weight loss is critical to overweight or obese patients with type 2 diabetes (T2D) for improving glycemic
control, cardiovascular risk factors, and quality of life. However, weight loss has been found to be associated
with increased bone loss and risk for fractures by many studies, including the Action for Health in Diabetes (Look
AHEAD) trial in which we observed an intensive lifestyle intervention (ILI) for weight loss was associated with
39% increased risk for frailty fracture (hip, pelvis, upper arm, or shoulder fractures) compared with diabetes
support and education (DSE) (control group) among overweight or obese patients with T2D. Frailty fractures are
devastating and represent a part of osteoporotic fracture types. We also observed the ILI was associated with
increased bone loss in a subgroup of Look AHEAD who also had dual-energy X-ray absorptiometry (DXA) scans.
However, the mechanisms linking the ILI and increased risk of fracture are still largely unknown but very
important for developing effective methods for protecting bone and preventing fracture during intentional weight
loss. The overall goal of this proposed study is to identify metabolomic changes which mediate the effect of ILI
on the increased risk for frailty fracture in the Look AHEAD trial using a state-of-the-art liquid chromatography-
mass spectrometry (LC-MS)-based metabolomics approach. In this study, we will include 4,659 Look AHEAD
participants (2,357 in ILI and 2,302 in DSE) who had blood samples collected at both baseline and the 1-year
visit and had a median follow-up of 11.3 years for fracture outcomes. Among those, 1,274 participants (642 in
ILI and 632 in DSE) also had DXA scans for bone mineral density (BMD) at both baseline and year 1. In this
study, we will further measure serum bone turnover markers (BTMs) and reanalyze DXA images to obtain the
trabecular bone score (TBS) to evaluate bone metabolism and bone microarchitecture (an indicator of bone
quality) in the DXA subgroup. A comprehensive two-stage metabolomics approach, including an
untargeted/global metabolomics analysis with relative quantification followed by chemical structure validation
and absolute quantification, will support the following Specific Aims: Aim 1) To examine the effects of ILI on
changes in metabolomic profiles from baseline to year 1; Aim 2) To examine whether 1-year changes in
metabolomic profiles are associated with and mediate the effect of ILI on the risk of frailty fracture; Aim 3) To
examine whether 1-year changes in metabolomic profiles are associated with changes in BTMs, BMD, and TBS;
and Aim 4) To examine whether baseline metabolomic profiles modify the effect of ILI on the risk of frailty fracture.
The proposed study will provide comprehensive insights into the biological mechanisms underlying the increased
risk of frailty fracture caused by the ILI. These findings will help discover molecular targets for blocking the
detrimental effect of intentional weight loss on bone health. The study will also provide novel biomarkers for
predicting the risk of frailty fracture and directing the personalization and optimization of lifestyle intervention for
weight loss among overweight and obese patients with T2D.
体重减轻对于超重或肥胖的2型糖尿病(T2D)患者改善血糖至关重要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAREN C JOHNSON其他文献
KAREN C JOHNSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAREN C JOHNSON', 18)}}的其他基金
Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk
利用健康信息技术控制肥胖以降低癌症风险
- 批准号:
10355938 - 财政年份:2022
- 资助金额:
$ 60.97万 - 项目类别:
Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk
利用健康信息技术控制肥胖以降低癌症风险
- 批准号:
10551269 - 财政年份:2022
- 资助金额:
$ 60.97万 - 项目类别:
Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes
超重或肥胖 2 型糖尿病患者的强化生活方式干预、代谢组学和衰弱性骨折风险
- 批准号:
10661065 - 财政年份:2021
- 资助金额:
$ 60.97万 - 项目类别:
Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes
超重或肥胖 2 型糖尿病患者的强化生活方式干预、代谢组学和衰弱性骨折风险
- 批准号:
10205545 - 财政年份:2021
- 资助金额:
$ 60.97万 - 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
- 批准号:
7918062 - 财政年份:2009
- 资助金额:
$ 60.97万 - 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
- 批准号:
8296227 - 财政年份:2009
- 资助金额:
$ 60.97万 - 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
- 批准号:
8101066 - 财政年份:2009
- 资助金额:
$ 60.97万 - 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
- 批准号:
8481573 - 财政年份:2009
- 资助金额:
$ 60.97万 - 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
- 批准号:
7700945 - 财政年份:2009
- 资助金额:
$ 60.97万 - 项目类别:
A Clinical Trial of Two Medications on Smoking Cessation
两种戒烟药物的临床试验
- 批准号:
6430710 - 财政年份:2002
- 资助金额:
$ 60.97万 - 项目类别:
相似海外基金
THALASSEMIA DATA AND BLOOD SPECIMEN COLLECTION SYSTEM
地中海贫血数据和血液样本采集系统
- 批准号:
7607252 - 财政年份:2007
- 资助金额:
$ 60.97万 - 项目类别:
THALASSEMIA DATA AND BLOOD SPECIMEN COLLECTION SYSTEM
地中海贫血数据和血液样本采集系统
- 批准号:
7380732 - 财政年份:2006
- 资助金额:
$ 60.97万 - 项目类别:
THALASSEMIA DATA AND BLOOD SPECIMEN COLLECTION SYSTEM
地中海贫血数据和血液样本采集系统
- 批准号:
7204708 - 财政年份:2005
- 资助金额:
$ 60.97万 - 项目类别:
2D SYMBOLOGY FOR CLINICAL BLOOD SPECIMEN HANDLING
临床血液样本处理的二维符号
- 批准号:
2286334 - 财政年份:1996
- 资助金额:
$ 60.97万 - 项目类别:
CLINICAL LABORATORY BLOOD SPECIMEN INSPECTION SYSTEM
临床实验室血液标本检测系统
- 批准号:
2030324 - 财政年份:1996
- 资助金额:
$ 60.97万 - 项目类别: